Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lingkang Huang

Interchangeability of PD-L1 Laboratory-Developed Test by 22C3 Antibody Concentrate Among Ihc Platforms in Gastric Cancer

Pathology

Forensic Medicine

Pathology

2020

English

Genes Related to Apoptosis Predict Necrosis of the Liver as a Phenotype Observed in Rats Exposed to a Compendium of Hepatotoxicants

English

Related publications

Using 22C3 Anti-Pd-L1 Antibody Concentrate on Biopsy and Cytology Samples From Non-Small Cell Lung Cancer Patients

Journal of Visualized Experiments

English

P2.09-08 Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Clinicopathological Features of 22C3 PD-L1 Expression With Mismatch Repair, Epstein–Barr Virus Status, and Cancer Genome Alterations in Metastatic Gastric Cancer

English

EBV-associated Gastric Cancer Evades T-Cell Immunity by PD-1/PD-L1 Interactions

English

P1.09-05 Why Does PD-L1 (22C3) Expression Rate Show Difference Among Regional Hospitals?

Journal of Thoracic Oncology

English

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer

Frontiers in Pharmacology

Pharmacology

2019

English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology

English

P3.09-02 Utilization of Laboratory Developed Tests for PD-L1 Evaluation Is Dependent on Tumor Type

Journal of Thoracic Oncology

English

PC06.02 Laboratory Developed Test - CON

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lingkang Huang

Interchangeability of PD-L1 Laboratory-Developed Test by 22C3 Antibody Concentrate Among Ihc Platforms in Gastric Cancer

Genes Related to Apoptosis Predict Necrosis of the Liver as a Phenotype Observed in Rats Exposed to a Compendium of Hepatotoxicants

Related publications

Using 22C3 Anti-Pd-L1 Antibody Concentrate on Biopsy and Cytology Samples From Non-Small Cell Lung Cancer Patients

P2.09-08 Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer

Clinicopathological Features of 22C3 PD-L1 Expression With Mismatch Repair, Epstein–Barr Virus Status, and Cancer Genome Alterations in Metastatic Gastric Cancer

EBV-associated Gastric Cancer Evades T-Cell Immunity by PD-1/PD-L1 Interactions

P1.09-05 Why Does PD-L1 (22C3) Expression Rate Show Difference Among Regional Hospitals?

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

P3.09-02 Utilization of Laboratory Developed Tests for PD-L1 Evaluation Is Dependent on Tumor Type

PC06.02 Laboratory Developed Test - CON